Cyclic Adenosine 3′:5′-Monophosphate-dependent Protein Kinase
Francis A. Neelon, Bruce M. Birch
openalex +1 more source
Vesicular stomatitis virus deficient in protein kinase is infectious [PDF]
K. B. Tan, H. F. Clark
openalex +1 more source
Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers
ABSTRACT Objective To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of iluzanebart, a fully human monoclonal antibody TREM2 (triggering receptor expressed on myeloid cells 2) agonist, after single‐ (SAD) and multiple‐ascending‐dose (MAD) administration.
Andreas Meier+8 more
wiley +1 more source
New Evidence for Compartmentalization of Ovarian 3′,5′-Cyclic AMP-Dependent Protein Kinase Activity12 [PDF]
Barry D. Albertson+1 more
openalex +1 more source
Universal Proteomic Signature After Exercise‐Induced Muscle Injury in Muscular Dystrophies
ABSTRACT Objective Several neuromuscular disorders (NMDs) are characterized by progressive muscle damage and are marked by the elevation of circulating muscle proteins from activity‐related injury. Despite a diverse array of genetic drivers, many NMDs share similar patterns of exercise intolerance and higher concentrations of muscle injury proteins ...
Mads G. Stemmerik+5 more
wiley +1 more source
Proteomics revealed novel functions and drought tolerance of Arabidopsis thaliana protein kinase ATG1. [PDF]
Cheng S, Fan S, Yang C, Hu W, Liu F.
europepmc +1 more source
Direct detection of protein kinases on electropherograms [PDF]
Lorenzo A. Pinna+2 more
openalex +1 more source
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis
ABSTRACT Objective This phase 3b, open‐label, randomized ADAPT NXT study investigated the efficacy, safety, and tolerability of efgartigimod administered in either a fixed cycles dosing regimen (3 cycles of 4 once‐weekly infusions, with 4 weeks between cycles) or a cycle followed by every‐other‐week (Q2W) dosing.
Ali A. Habib+16 more
wiley +1 more source
Hypoglycaemic stimulation of macrophage cytokine release is suppressed by AMP-activated protein kinase activation. [PDF]
Zhang J+6 more
europepmc +1 more source